Average Co-Inventor Count = 5.84
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (30 from 3,681 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
31 patents:
1. 12419953 - Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies
2. 12409223 - Antagonistic CD40 monoclonal antibodies and uses thereof
3. 12065505 - Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof
4. 11926673 - Antagonistic CD40 monoclonal antibodies and uses thereof
5. 11813315 - Fibronectin based scaffold domain proteins that bind to myostatin
6. 11795231 - Antagonistic CD40 monoclonal antibodies and uses thereof
7. 11773178 - Antagonistic CD40 monoclonal antibodies and uses thereof
8. 11623965 - Prodruggable antibodies, prodrugs thereof, and methods of use and making
9. 11524992 - Glypican-3-binding fibronectin based scaffold molecules
10. 11512124 - Fibronectin type III domain proteins with enhanced solubility
11. 11434275 - Fast-off rate serum albumin binding fibronectin type III domains
12. 11261258 - Antagonistic CD40 monoclonal antibodies and uses thereof
13. 11254750 - Antagonistic CD40 monoclonal antibodies and uses in treating immune responses
14. 10787498 - Fibronectin type III domain proteins with enhanced solubility
15. 10766946 - Fast-off rate serum albumin binding fibronectin type III domains